Amantadine Treatment for Hyperkinetic Movements in Chorea‐Acanthocytosis
Sign Up to like & getrecommendations! Published in 2022 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13623
Abstract: A 38-year-old Caucasian female presented with 2 years of progressive involuntary movements, dysarthria, sialorrhea, dysphagia, gait impairment, and restlessness. She denied prior use of neuroleptics. Levodopa (400 mg/day), glycopyrrolate, pro-pranolol (40 mg/day), clonazepam (2 mg/day),… read more here.
Keywords: day; treatment hyperkinetic; hyperkinetic movements; amantadine treatment ... See more keywords
Efficacy and safety of amantadine as a treatment for apathy after brain injury: Two single-case experimental design studies.
Sign Up to like & getrecommendations! Published in 2020 at "Neuropsychological rehabilitation"
DOI: 10.1080/09602011.2020.1842214
Abstract: Studies on the efficacy of amantadine as a treatment for apathy after brain injury are scarce and of low quality. We examined the efficacy and safety of amantadine for treatment of apathy in two individuals… read more here.
Keywords: brain injury; amantadine; amantadine treatment; case ... See more keywords